[Retracted] Downregulated Expression of miRNA-130a-5p Aggravates Hepatoma Progression via Targeting PTP4A2

Table 1

Correlations between miRNA-130a-5p and the clinicopathological parameters of hepatoma patients (, test).

Variable	MiRNA-130a-5p expression		value
	High	Low
	20	20
Age (year)			0.097
<60	10	4
≥60	10	16
Gender			0.723
Female	6	5
Male	14	15
Tumor size			0.004
<5 cm	6	16
≥5 cm	14	4
TNM stage			0.011
I–II	7	16
III–IV	13	4
Liver cirrhosis			0.677
Yes	16	17
No	4	3
AFP (ng/mL)			0.157
≤200	12	17
>200	8	3
HBsAg			0.273
Positive	17	13
Negative	3	7
Edmondson grade			0.024
I–II	8	16
III–IV	12	4